Skip to content

13F-HR filed by ABG-WTT Global Life Science Capital Partners GP Ltd

ABG-WTT Global Life Science Capital Partners GP Ltd filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 4 holding rows worth $38,322,526.

Accession
0000950123-25-005578
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 4 entries on the cover page, a total value of $38,322,526 stated on the cover page (in dollars after the unit check, H1), rows summing to $38,322,526 with VALUE read as dollars as filed, 13F file number 028-20836. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CERIBELL INC15678C102COMMON STOCK1,088,101$20,902,420dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK495,526$12,135,432dollars as filed
RAPID MICRO BIOSYSTEMS INC75340L104CLASS A COM1,848,296$4,879,501dollars as filed
PULMONX CORP745848101COM60,204$405,173dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-25-005578this filing2025-05-15acceptance time not in the bulk data set